BBI•benzinga•
Brickell Biotech Announces Sale Of Sofpironium Bromide To Botanix Pharmaceuticals; Deal Includes Up To $9M In Upfront And Potential Near-term Regulatory Milestone Payments, $168M In Potential Future Regulatory And Sales Milestone Payments
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 3, 2022 by benzinga